This topic contains a solution. Click here to go to the answer

Author Question: The nurse has just administered parasympathomimetic ophthalmic drops to a patient to reduce ... (Read 90 times)

Yi-Chen

  • Hero Member
  • *****
  • Posts: 550
The nurse has just administered parasympathomimetic ophthalmic drops to a patient to reduce intraocular pressure in the treatment of glaucoma.
 
  Which clinical finding would the nurse expect as a response to the administration of the eye drops?
  a. Mydriasis
  b. Miosis
  c. Decreased drainage of aqueous humor
  d. Pupillary dilation

Question 2

Which of the following beta blockers used in the treatment of glaucoma pose or poses the least risk for patients with asthma and chronic obstructive pulmonary disease? (Select all that apply.)
 
  a. Betaxolol
  b. Carteolol
  c. Levobetaxolol
  d. Metipranolol
  e. Timolol



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

milbourne11

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

ANS: B
Miosis, or pupillary constriction, would be expected as a result of the parasympathomimetic response.
A sympathetic response would be mydriasis, or pupillary dilation.
These medications do not reduce the drainage of the aqueous humor.

Answer to Question 2

ANS: A, C
Only two ophthalmic beta blockers, betaxolol and levobetaxolol, are beta1 selective and therefore are preferred for patients with asthma and chronic obstructive pulmonary disease (COPD), because they pose the least risk to these patients.
Carteolol, metipranolol, and timolol are nonselective, which means that they block both beta1 and beta2 receptors. Blockade of beta2 receptors in the lung can lead to bronchospasm in patients with reactive airway disease.




Yi-Chen

  • Member
  • Posts: 550
Reply 2 on: Jul 23, 2018
Wow, this really help


Dinolord

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

The human body produces and destroys 15 million blood cells every second.

For a complete list of videos, visit our video library